France Self-Monitoring Blood Glucose Devices Market Size (2024 - 2029)

The France Self-Monitoring Blood Glucose Devices Market is projected to experience significant growth over the forecast period, driven by the increasing importance of blood glucose monitoring in managing diabetes and preventing complications. The market's expansion is supported by innovative technologies, such as digital health apps and integrated monitoring systems, which enhance self-management and reduce the disease burden. These advancements not only improve patient outcomes but also contribute to the overall growth potential of the market.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Monitoring Devices Research Single time Monitoring Devices Research France Self-Monitoring Blood Glucose Devices Market Market Size

Market Size of France Self-Monitoring Blood Glucose Devices Industry

France Self-Monitoring Blood Glucose Devices Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 532 Million
Market Size (2029) USD 712 Million
CAGR (2024 - 2029) 7.18 %

Major Players

France Self-Monitoring Blood Glucose Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

France Self-Monitoring Blood Glucose Devices Market Analysis

The France Self-Monitoring Blood Glucose Devices Market size is estimated at USD 532 million in 2024, and is expected to reach USD 712 million by 2029, growing at a CAGR of 7.18% during the forecast period (2024-2029).

Blood glucose monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values help provide feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.

Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and incorporate additional relevant data such as insulin doses, meals and snacks, and physical activity, can further support self-management while decreasing disease burden and benefiting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes with the additional support needed to improve critical outcomes, thereby enhancing market prospects in the years to come.

France Self-Monitoring Blood Glucose Devices Industry Segmentation

Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The French self-monitoring blood glucose device market is segmented by components. The report offers the value (in USD) and volume (in unit) for the above segments.

Component
Glucometer Devices
Test Strips
Lancets
Need A Different Region Or Segment?
Customize Now

France Self-Monitoring Blood Glucose Devices Market Size Summary

The France self-monitoring blood glucose devices market is poised for significant growth over the forecast period, driven by the increasing prevalence of diabetes and advancements in medical technology. These devices play a crucial role in helping patients manage their condition by providing real-time feedback on blood glucose levels, which is essential for making informed lifestyle and treatment decisions. The integration of innovative technologies, such as digital health apps and automated insulin titration software, enhances the self-management capabilities of patients, thereby reducing the disease burden and improving overall diabetes care. The French healthcare system's support for diabetes management, including coverage under the ALD scheme, further bolsters the market's growth prospects.

The market is characterized by a fragmented landscape with several key players, including Abbott, LifeScan, Roche, and Ascensia, who hold significant market shares. The test strip segment dominates the market due to its essential role in blood glucose testing and the recurring need for replacements, which ensures a steady revenue stream. The French healthcare system, primarily funded by taxes, offers substantial coverage for diabetes-related medical costs, encouraging the adoption of self-monitoring devices. Recent innovations, such as Bluetooth-connected meters and advanced point-of-care monitors, underscore the ongoing advancements in the sector, promising continued growth and improved patient outcomes in the coming years.

Explore More

France Self-Monitoring Blood Glucose Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Component

      1. 2.1.1 Glucometer Devices

      2. 2.1.2 Test Strips

      3. 2.1.3 Lancets

France Self-Monitoring Blood Glucose Devices Market Size FAQs

The France Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 532 million in 2024 and grow at a CAGR of 7.18% to reach USD 712 million by 2029.

In 2024, the France Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 532 million.

France Self-Monitoring Blood Glucose Devices Market Report Snapshots

France Self-Monitoring Blood Glucose Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)